Evidence map›Paper›PMID 27956424›Full record

ArticleAntimicrobial agents and chemotherapy2017

Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

F Robin, R Beyrouthy, S Bonacorsi, N Aissa, L Bret, N Brieu, V Cattoir, A Chapuis, H Chardon, N Degand and 14 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Systematic review of multidrug-resistantFrontiers in microbiology · 2025
    Pooled it
  2. Comparison of three immunochromatographic assays for the rapid detection of CTX-M in Enterobacterales.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Multiplex microarray PCR Unyvero BCU system to accelerate relevant antimicrobial treatment in polymicrobial bloodstream infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Article
  5. Article
  6. Emergence of a Novel Lineage and Wide Spread of aAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Wide Spread ofFrontiers in microbiology · 2020
    Article
  15. Review
  16. High Prevalence of ST131 Subclades C2-Frontiers in cellular and infection microbiology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Antimicrobial agents and chemotherapy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 1 country.

F RobinCHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France frobin@chu-clermontferrand.fr.
R BeyrouthyCHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
S BonacorsiUMR INSERM 1137, IAME, Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
N AissaLaboratoire de Bactériologie, CHRU de Nancy, Nancy, France.
L BretDepartment of Microbiology, La Source Hospital, CHR Orléans, Orléans, France.
N BrieuCH du Pays d'Aix, Laboratoire de Diagnostic Biologique des Maladies Infectieuses et d'Hygiène, Aix-en-Provence, France.
V CattoirCHU de Caen, Service de Microbiologie, Université de Caen Basse-Normandie, EA4655 (équipe Antibiorésistance), Caen, France.
A ChapuisDepartment of Bacteriology, University Hospital of Dijon, BP 37013, Dijon, France.
H ChardonCH du Pays d'Aix, Laboratoire de Diagnostic Biologique des Maladies Infectieuses et d'Hygiène, Aix-en-Provence, France.
N DegandLaboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital Archet II, Nice, France.
F Doucet-PopulaireService de Bactériologie-Hygiène, Hopital Antoine Béclère, APHP, Université Paris Sud, Clamart, France.
V DuboisUMR 5234 CNRS, University Bordeaux 2, Bordeaux, France.
N FortineauService de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
A GrillonPlateau technique de microbiologie, Laboratoire de bactériologie, CHU Strasbourg, Strasbourg, France.
P LanotteCHU de Tours, Laboratoire de Bactériologie, Tours, France; Université François Rabelais, E5 Bactéries et risque materno-fœtal, UMR 1282 ISP, INRA, Nouzilly, France.
D LeysseneLaboratoire de Biologie médicale, Centre hospitalier de la Côte Basque, Bayonne, France.
I PatryLaboratoire de Bactériologie, Centre Hospitalier Universitaire de Besançon, Besançon, France.
I PodglajenMicrobiology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
C ReculeBacteriology Department, CHU Grenoble, Grenoble, France.
A RosLaboratoire de Bactériologie-Virologie-Hygiène, CHU de Saint-Etienne, Saint-Etienne, France.
M Colomb-CotinatDepartment of Infectious Diseases, Institut de Veille Sanitaire, French Institute for Public Health Surveillance, Saint-Maurice, France.
V PontiesDepartment of Infectious Diseases, Institut de Veille Sanitaire, French Institute for Public Health Surveillance, Saint-Maurice, France.
M C PloyLaboratoire de bactériologie-virologie-hygiène, centre hospitalier universitaire de Limoges, Limoges, France.
R BonnetCHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier du Pays d'Aix · FRInstitut de Veille Sanitaire · FRCentre Hospitalier de la Côte Basque · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Limoges · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Saint-Étienne · FRCentre hospitalier universitaire d'Orléans · FRCentre National de la Recherche Scientifique · FRMaison des Sciences sociales et des Humanités de Dijon · FRUniversité de Tours · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to perform an inventory of the extended-spectrum-β-lactamase (ESBL)-producing

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsChildChild, PreschoolClone CellsDrug Resistance, Multiple, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsFemaleFranceGene ExpressionAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsAAC(3)-IIAAC(6′)-IbESBLplasmidplasmid-mediated quinolone resistanceplasmid-mediated resistance

Identifiers

PMID27956424
PMCPMC5328551
OpenAlexW2563518811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.